Cargando…
Designing molecular diagnostics for current tuberculosis drug regimens
Diagnostic development must occur in parallel with drug development to ensure the longevity of new treatment compounds. Despite an increasing number of novel and repurposed anti-tuberculosis compounds and regimens, there remains a large number of drugs for which no rapid and accurate molecular diagn...
Autores principales: | Georghiou, Sophia B., de Vos, Margaretha, Velen, Kavindhran, Miotto, Paolo, Colman, Rebecca E., Cirillo, Daniela Maria, Ismail, Nazir, Rodwell, Timothy C., Suresh, Anita, Ruhwald, Morten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980415/ https://www.ncbi.nlm.nih.gov/pubmed/36752055 http://dx.doi.org/10.1080/22221751.2023.2178243 |
Ejemplares similares
-
What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis
por: Stagg, H R, et al.
Publicado: (2016) -
Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial
por: Zheng, Xubin, et al.
Publicado: (2023) -
Presentation and healthcare delays among people with tuberculosis in London, and the impact on treatment outcome
por: Evenden, Poppy, et al.
Publicado: (2019) -
Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study
por: Ghimire, Samiksha, et al.
Publicado: (2020) -
Pictorial essay: Orbital tuberculosis
por: Narula, Mahender K, et al.
Publicado: (2010)